Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation
Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Antivirals such as valacyclovir act against viruses and may be effective in
preventing cytomegalovirus. It is not yet known if valacyclovir is effective in preventing
cytomegalovirus in patients undergoing stem cell transplantation.
PURPOSE: Randomized phase III trial to determine the effectiveness of valacyclovir in
preventing cytomegalovirus in patients who are undergoing donor stem cell transplantation.